Pre-IPO OrbusNeich Medical Group - The Industry, the Business and the Concerns
The rich pipeline and large global business will help OrbusNeich “hedge” negative domestic policy impact. But fierce competition, slow progress in...
Pre-IPO Shanghai NewMed Medical - Concerns on Fierce Competition and Future Commercialization
We analyzed the industry characteristics of heart valve device market. Concerns of NewMed are mainly the slow product development progress, fierce...
ECM Weekly (5th September 2021) - JR West, Kakaobank, Helen's, ANE, Weilong Snacks, NewMed
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
NewMed (纽脉医疗) Pre-IPO: Uphill Battle for TAVR but Leads the TMVR
NewMed plans to raise at least USD 200m via a Hong Kong listing. We take a look at its Prizvalve, replacement valve for the aortic valve, and Mi...
No more insights